Articles Index

Byetta - A New Approach For Type 2 Diabetes

Byetta is the first of a new class of drugs available for Type 2 diabetes management. It's not used for Type 1. It's been on the market for about a year. It is meant to be a supplemental drug, used in conjunction with Metformin or sulfonylureas or a combination of both to help improve glycemic control in people who have had trouble maintaining good blood glucose levels.

Oral Medications for Managing Type 2 Diabetes

These six classes of oral drugs manage most type 2 diabetes patients: sulfonylureas, biguanides, thiazolidinediones, alpha-glucosidase inhibitors, meglitinides and DPP-4 Inhibitors. Each of these classes of drugs works in different ways to help diabetes patients to maintain good glucose control.

Januvia - A New Drug For Type 2

A new oral medication called Januvia (sitagliptin phosphate) has been approved by the FDA for management of Type 2 diabetes. It's the first in a new class of drugs called DPP-4 Inhibitors.

Insulin Pump Therapy

Insulin pumps first came on the medical scene over 20 years ago. In the last decade, they have evolved into an effective way to help people with diabetes achieve more flexibility in their lifestyles while maintaining tighter control of their blood glucose levels. Pumps offer these benefits by administering a basal rate of insulin continuously while allowing boluses of insulin during times when you need it.

Symlin - A New Class of Diabetes Medication

Symlin (pramlintide) is a new class of diabetes drug to manage both type 1 and type 2 diabetes. It is a synthetic form of amylin, which is a hormone usually produced in the pancreas. Pramlintide can help control postprandial blood sugar, when combined with insulin therapy.